Literature DB >> 9565205

Estimation of the prevalence of injection drug use in greater Boston in 1993.

R C Wolf1, P Case, M Pagano.   

Abstract

This article is a report on different methods of estimation of the number of injection drug users (IDUs) in the Boston standard metropolitan statistical area (SMSA) in 1993. Because the sharing of needles is a means of transmission for HIV, an estimate of the prevalence of injection drug use is essential for acquired immunodeficiency syndrome (AIDS) prevention programs. The data for this study come from the Massachusetts Department of Public Health Bureau of Substance Abuse, the Massachusetts AIDS Surveillance Unit, the Drug Abuse Warning Network (DAWN), the National Household Survey on Drug Abuse: Population Estimates 1993, and the Massachusetts State Police Crime Reporting Unit. The estimates in this study can be assessed with regard to the different time frames that are involved, noting that some estimates are useful only to establish upper or lower bounds. The estimate that best meshes with the findings of this report is that there were between 13,500-16,500 injection drug users in greater Boston and 45,000-60,000 IDUs in Massachusetts in 1993.

Entities:  

Mesh:

Year:  1998        PMID: 9565205     DOI: 10.1080/02791072.1998.10399667

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  2 in total

1.  Estimating the population of female sex workers in two Chinese cities on the basis of the HIV/AIDS behavioural surveillance approach combined with a multiplier method.

Authors:  Dapeng Zhang; Fan Lv; Liyan Wang; Liangxian Sun; Jian Zhou; Wenyi Su; Peng Bi
Journal:  Sex Transm Infect       Date:  2006-11-07       Impact factor: 3.519

2.  Hepatitis C risk assessment, testing and referral for treatment in urban primary care: role of race and ethnicity.

Authors:  Stacey B Trooskin; Victor J Navarro; Robert J Winn; David J Axelrod; A Scott McNeal; Maricruz Velez; Steven K Herrine; Simona Rossi
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.